4D Molecular Therapeutics (FDMT) Research & Development (2020 - 2025)
Historic Research & Development for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Q3 2025 value amounting to $49.4 million.
- 4D Molecular Therapeutics' Research & Development rose 2846.38% to $49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $181.2 million, marking a year-over-year increase of 4582.43%. This contributed to the annual value of $141.3 million for FY2024, which is 4552.5% up from last year.
- According to the latest figures from Q3 2025, 4D Molecular Therapeutics' Research & Development is $49.4 million, which was up 2846.38% from $48.0 million recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Research & Development ranged from a high of $49.4 million in Q3 2025 and a low of $12.8 million during Q1 2021
- Over the past 5 years, 4D Molecular Therapeutics' median Research & Development value was $23.6 million (recorded in 2023), while the average stood at $27.3 million.
- Per our database at Business Quant, 4D Molecular Therapeutics' Research & Development crashed by 316.16% in 2021 and then soared by 6554.1% in 2024.
- Over the past 5 years, 4D Molecular Therapeutics' Research & Development (Quarter) stood at $17.5 million in 2021, then rose by 22.66% to $21.5 million in 2022, then grew by 21.06% to $26.0 million in 2023, then skyrocketed by 65.54% to $43.1 million in 2024, then grew by 14.74% to $49.4 million in 2025.
- Its Research & Development stands at $49.4 million for Q3 2025, versus $48.0 million for Q2 2025 and $40.7 million for Q1 2025.